Fig. 9From: Phosphorylation of NF-κBp65 drives inflammation-mediated hepatocellular carcinogenesis and is a novel therapeutic targetDiagram of the mechanism by which NF-κBp65 phosphorylation drives hepatocellular carcinogenesis. Inflammation, such as TNF-α, induces ARRB1 and promotes ARRB1 binding to NF-κBp65, facilitating the phosphorylation of p65 at ser536. Then, the phosphorylation of p65 (Ser536) activates Akt/mTOR signalling to drive malignant hepatocellular proliferation, resulting in hepatocellular carcinogenesisBack to article page